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Phospholipids and lung surfactant proteins are known to be recycled within the lung alveolus mainly by uptake into type II
epithelial cells that secrete lipid-enriched lung surfactant. Dipalmitoyl phosphatidylcholine (DPPC) is the major component of
lung surfactant lipids and cholesterol is the second most abundant. However, cholesterol turnover in vivo has not been measured
and it is not known how long steroidal compounds persist in the lung in intact animals. Here we report on experiments in which
radiolabeled cholesterol was instilled into the lungs of rats, then at various postinstillation periods, radioactive sterols in lavage
ﬂuid, and in postlavage whole lungs were measured in individual animals. Radioactive sterols in the lungs remained high for a
week and were still detectable 46 days later. The clearance rate during the initial postinstillation week was approximately 10% per
day. Both radioactive free and esteriﬁed sterols were recovered from bronchoalveolar lavage ﬂuid and postlavage lungs.
1.Introduction
Lung surfactant is maintained at precise concentrations
in the alveolar space by the regulation of synthesis and
catabolism of surfactant components [1]. Furthermore, lung
surfactantapoproteinsandphospholipidsarerecycledwithin
the mammalian lung [2–13], primarily by mechanisms
involving alveolar epithelial type II pneumocyte uptake
and secretion. Electron microscopic cytochemical and bio-
chemical subcellular fractionation experiments demonstrate
binding and uptake of labeled surfactant components by
type II pneumocytes [5, 7, 9, 11, 12]. The labeled material
becomes associated with intracellular organelles such as
endosomes and multilamellar bodies and in various cyto-
plasmic subcellular fractions. Studies on recycling, clearance
and lung compartmentalization of surfactant components
were performed using in vitro, ex vivo, and in vivo studies
[1, 5, 8, 11, 12]. Radiolabeled compounds or tagged material
visualized by microscopy have been employed to follow
the translocation of Surfactant Protein A (SP-A) and the
dominant lung surfactant component dipalmitoyl phos-
phatidylcholine (DPPC). The majority of reports to date are
on experiments in which the labeled surfactant compound
is analyzed within minutes to hours after exposure to
the label. For example, studies have been performed on
perfused lung preparations using small animals [2, 4]. Also,
a recent study involving gamma scintigraphy technology was
employed in humans to follow deposition and clearance
in vivo of aerosolized
99mTc liposomes containing DPPC,
cholesterol, and amikacin for 72 hours [13]. However, there
i sal a c ko fd a t ao nc l e a r a n c eo rt u r n o v e rr a t e si nv i v oo f
sterols in laboratory animal lung surfactant for comparative
purposes [1, 8, 14]. In the present study, we measured the
clearancerateofradiolabeledcholesterolinvivoinintactrats
and examined the extent to which radiolabeled cholesterol
was retained in rat lungs after several days to weeks post
instillation.
2.MaterialsandMethods
2.1. Instillation of Radiolabeled Cholesterol into Animal Lungs.
The lungs of viral antibody-negative female Lewis rats
(Harlan Sprague-Dawley, Indianapolis, IN) that weighed
between 243g and 325g were intratracheally instilled with
radiolabeled cholesterol. The material instilled was prepared
using [1, 2-3H]cholesterol obtained from Amersham (Pis-
cataway, NJ; sp. act. 48Ci/mmol). Forty mCi in 4mL of
toluene was placed in a 15mL glass tube, dried under
N2, and then 1.2mL of a buﬀered solution (150mMNaCl,
1.8mMCaCl2,2 5 m M H E P E S ,p H7 . 4 ,3 2 9 m O s m )w a s2 Biochemistry Research International
added. After vortex agitation and sonication for 15 minutes,
the micellar suspension clariﬁed.
The rats were mildly anesthetized with 70% CO2, then
the cholesterol suspension was brought up into a syringe,
and 0.15mL (400μCi) were intratracheally instilled into
individual rats using a 20-gauge curved stainless steel animal
feeding tube (Popper and Sons, New Hyde Park NY) [15,
16]. At diﬀerent time-points post instillation, rats were
sacriﬁced with halothane, and their lungs were lavaged
three times, each time using 1mL of the HEPES-buﬀered
solution described above. The three bronchoalveolar lavage
ﬂuid (BALF) samples were pooled. The postlavage lungs
were ﬁrst perfused via the right atrium to remove blood
elements and then excised. Excised lungs were cut into small
pieces and homogenized using a Stomacher lab blender 80
(Tekmar,Cincinnati,OH)priortolipidextraction.Protocols
forthisstudywereapprovedbytheInstitutionalAnimalCare
and Use Committee and the Radiation Safety Oﬃce of the
University of Cincinnati.
2.2. Extraction of Lipids and Isolation and Analysis of Sterols.
Total lipids were extracted for 1 hour at room temperature in
chloroform (CHCl3) and methanol (MeOH); ﬁnal propor-
tions of CHCl3 : MeOH : BALF or postlavage lung pieces
w e r e1:2:0 .8 (v/v/v) [17]. Particulates were removed from
the postlavage lung samples by centrifugation at 1,500g for
10 minutes. Lipids in extracts of BALF and postlavage lungs
were puriﬁed by biphasic partitioning [18]; ﬁnal proportions
of CHCl3 :M e O H:H 2Ow e r e2:1:0 .75 (v/v/v). The lower
organic phase containing the total lipid fraction was dried
under N2 and quantiﬁed gravimetrically.
Sterols were isolated by thin-layer chromatography
(TLC) using glass-backed 250-μm-thick Silica Gel G plates
(AnalTech, Newark, DE) and developed in petroleum ether :
diethyl ether : acetic acid (80 : 20 : 1, v/v/v) as the solvent
system. Following development, the lipid bands were iden-
tiﬁed by visualization using I2 vapor, and the bands cor-
responding to free cholesterol (Rf = 0.22), other sterols
(Rf = 0.30), and the steryl esters (Rf = 0.85) were scraped
oﬀ the plates, and radioactivity of these fractions were
measured by liquid scintillation spectrometry. Authentic
cholesterol,lanosterol,andcholesterylpalmitatewereusedas
standards. Statistical analyses and production of illustrations
were performed using Microsoft Excel software.
3. Results andDiscussion
3.1. Total [3H]Cholesterol in BALF and Postlavaged Rat Lungs.
Under the experimental protocol used in this study, indi-
vidual animals could not be monitored over time since rats
needed to be sacriﬁced to obtain lungs. Hence, the amount
of radioactive cholesterol that had been successfully instilled
into the lung alveoli of each rat could not be determined
and variations in data would be expected due to individual
diﬀerences among animals. After diﬀerent periods following
instillation, the sterols in BALF and postlavage lungs of
individual animals were found to contain radioactive sterols,
indicating that radiolabeled cholesterol reached the lungs of
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Figure 1: Clearance of radioactivity from [3H]cholesterol instilled
into rat lungs. Values represent total radioactivities in TLC-isolated
bands corresponding to free sterols and steryl esters. BALF (circles)
andpostlavagelung(squares).Eachvaluerepresentsasinglesample
from an individual rat.
each experimental rat. The radioactivity was higher in lipids
extracted from animals sacriﬁced earlier compared to that
in animals sacriﬁced later (Figure 1). The radioactivity in
theTLCfractionscorrespondingtoauthenticfreecholesterol
and steryl esters ranged from 7.9×103 dpm to 6.3×105 dpm
(BALF) and from 6.4×105 dpm to 1.7×107 dpm (postlavage
lungs). The clearance rates of [3H]cholesterol from the BALF
andpostlavagelungwereapproximately9%perdayand10%
per day, respectively.
After 46 days post instillation, radioactivity in sterols was
still detected in lung samples. At that time, the radioac-
tivity of the free cholesterol TLC fraction was 5,734dpm
(3,066dpm/mg total lipids) in the BALF and 48,723dpm
(1,372dpm/mg total lipids) in the postlavage lung. The
TLC band corresponding to other sterols was radioactive
suggesting metabolism of the instilled cholesterol or that
tritium exchange had occurred. The radioactivity in the TLC
steryl ester fraction was 375dpm (201dpm/mg total lipids)
for the BALF, and 979dpm (28dpm/mg total lipids) for the
postlavage lung.
3.2. Free Cholesterol in BALF and Postlavage Lungs. Since
[3H]cholesterolwasinstilledintothetrachea,thiscompound
would ﬁrst be expected to reside in the hyperphase ﬂuid
lining the alveoli, which is sampled during bronchoalveolar
lavaging. Our data indicate that after 24 hours, the radi-
olabeled compound must have been readily taken up by
pneumocytes since most of the label in the free cholesterol
fraction was in the postlavage rat lung tissue compared
to the compartment accessible for recovery in lavage ﬂuid
(Figure 2(a)).
3.3. Radioactive Steryl Esters in BALF and Postlavaged Rat
Lungs. Rat lungs contain very low levels of steryl esters
compared to free sterols [19], and in the present study,
higher radioactivity was found in free sterols (Figure 2(a))Biochemistry Research International 3
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Figure 2: Clearance of radioactivity from [3H]cholesterol-instilled
rat lungs. Free sterol and the steryl ester fractions were isolated
by TLC from BALF (circles) and postlavage lungs (squares). (a)
Radioactivity in TLC band corresponding to free cholesterol. (b)
Radioactivity in steryl esters.
compared to steryl esters (Figure 2(b)). Radioactivity was
detected in all steryl ester samples and ranged from 926 to
52,375dpm in BALF lipids, and from 1,176 to 128,212dpm
inpostlavagelunglipids.Itisnotknownwhethertheinstilled
[3H]cholesterol is esteriﬁed within pneumocytes, such as the
type II epithelial cells, within other cells in the lung such as
macrophages, or in nonpulmonary tissues of the body.
3.4. Comparison with Other Studies on Lung Surfactant
Turnover. In experiments performed on rabbits by other
investigators, both radiolabeled SP-A and DPPC and other
phospholipids were initially cleared from the lungs at
exponential rates and then at a slower linear rate [1, 8]. Since
SP-A disappeared at a faster rate than DPPC, this indicated
separate pathways for secretion of these two major compo-
nents of lung surfactant [1, 9]. In the present study, the ﬁrst
measurements were taken 1 day post instillation. Together
with data in the literature on rabbits [10], we tentatively
conclude that our results reﬂect the linear clearance rate of
∼10% per day that may occur following an initial rise and
steepdecreaseseenatearliertimesintherabbitlung[10]and
human [13] studies. Hence only low percentages of instilled
radioactivity were recovered in free cholesterol and steryl
esters present in BALF and postlavaged lungs after a period
of days (Figure 1)a n dw e e k s .
The formation of cholesterol esters from instilled radi-
olabeled free cholesterol can occur rapidly [20]. Using an
isolated perfused rat lung preparation, Hayball and Nicholas
[20] reported that an alveolar macrophage-enriched fraction
of BALF contained higher levels of the cholesterol esters
compared to the surfactant-enriched fraction of BALF.
However, they reported that radiolabeled cholesterol esters
were not formed in vitro when radiolabeled free cholesterol
was incubated with these cell fractions. Isolated alveolar
epithelial cells or postlavage lungs were not tested in that
study. Thus, it is likely that at least some of the radioactive
cholesteryl esters detected in the present study might have
formed in the lung in vivo. However, the data in an earlier
report [20] and those in the present study do not rule out
the possibility that cholesterol is translocated to other tissues
of the rat, esteriﬁed or otherwise metabolized, and then
translocated back to the lung.
3.5. Translocation of Sterols in Animals. In the present in vivo
study, radioactivity was also detected in liver, mesenteric fat,
feces, heart, blood, and urine in rats from day 1 to day 8 post
instillation, indicating that cholesterol is readily translocated
to diﬀerentorgansandtissuesoftherat.Thetotalradioactiv-
ity recovered from lungs after days or weeks post instillation
must strongly reﬂect the elimination of radiolabeled choles-
terol by other organs in the animals. Cholesterol would be
expected to be readily imported into the rat lung since it has
been reported that de novo sterol synthesis does not occur in
this organ [21] and 3-hydroxy-3-methylglutaryl Coenzyme
A(HMG-CoA)reductaseactivitywasundetectableoratonly
very low levels in rat lung tissue [22].
4. Conclusions
Data obtained in this study showed that radioactivity from
cholesterol instilled in vivo into rat lungs was detected in
both BALF and postlavage lung lipids after several weeks
and that the clearance rate over the initial period of a week
was calculated at approximately 10% per day. Although the
radioactive sterols measured in the lungs after instillation of
[3H]cholesterol are very likely inﬂuenced by elimination and
metabolism by other organs in the rat, the results of this
study showed the persistence of high levels of radiolabeled
cholesterol in the rat lung. This is the ﬁrst study in which
cholesterol clearance was performed in vivo over days and
weeks in intact laboratory animals. The data reported here
are consistent with other evidences of recycling of lung
surfactant components in the mammalian lung.4 Biochemistry Research International
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